Triall
Maarssen
About Triall
Triall brings Web3 to medical research by creating a digital ecosystem of blockchain-integrated software solutions that secure and streamline clinical trials. Triall’s solutions make clinical trials tamper-resistant and enable secure and efficient integrations between the many isolated systems and parties involved in clinical trial processes. Triall’s software is co-created with clinical trial professionals to ensure optimal user experience, solving actual industry pain points.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $2.4M
- Funding stage: Seed
- Last round: Seed (Jul 2021)
- Website: triall.io
- Phone: [email protected]
Industries & Categories
Clinical Trials, Health Care, Information Technology, Life Science, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/triall-192164 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.